✦ LIBER ✦

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

✍ Scribed by Di Costanzo, F; Carlini, P; Doni, L; Massidda, B; Mattioli, R; Iop, A; Barletta, E; Moscetti, L; Recchia, F; Tralongo, P

Book ID: 109998544
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 97 KB
Volume: 93
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602640

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine, ifosfamide, cisplatin (GIP)

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

✍ C. Boni; G. Bisagni; L. Savoldi; G. Moretti; E. Rondini; M. Sassi; A. Zadro; T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

Preliminary report of high dose folinic

Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: A randomized trial of the italian oncology group for clinical research

✍ Francesco Di Costanzo; Paolo Malacarne; Sandra Zironi; Marina Marzola; Enrica Co 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat